(Q51019520)

27 March 2018

title

Sominone improves memory impairments and increases axonal density in Alzheimer's disease model mice, 5XFAD. (English)

1 reference

27 March 2018

1 reference

Eri Joyashiki

1

1 reference

27 March 2018

Yuji Matsuya

series ordinal

2

1 reference

27 March 2018

Chihiro Tohda

series ordinal

3

1 reference

27 March 2018

publication date

1 April 2011

1 reference

27 March 2018

International Journal of Neuroscience

published in

1 reference

27 March 2018

volume

121

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

181-190

1 reference

27 March 2018

GDNF signaling in embryonic midbrain neurons in vitro

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Plaques, tangles, and memory loss in mouse models of neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Neuritic regeneration and synaptic reconstruction induced by withanolide A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Synthesis of sominone and its derivatives based on an RCM strategy: discovery of a novel anti-Alzheimer's disease medicine candidate "denosomin".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Failures to reconsolidate memory in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Search for natural products related to regeneration of the neuronal network.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Repair of amyloid β(25–35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.541571

10.3109/00207454.2010.541571

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018